×
For best experience we recommend to activate Javascript in your browser.
SOX10 antibody (C-Term)
SOX10
Reactivity: Human
IHC (p)
Host: Rabbit
Monoclonal
I25-T
unconjugated
Product Details anti-SOX10 Antibody
(hide)
Target
See all SOX10 Antibodies
SOX10
(SRY (Sex Determining Region Y)-Box 10 (SOX10))
Binding Specificity
All epitopes for SOX10 antibodies
C-Term
Reactivity
All reactivities for SOX10 antibodies
Human
Host
All hosts for SOX10 antibodies
Rabbit
Clonality
All clonalities for SOX10 antibodies
Monoclonal
Conjugate
All conjugates for SOX10 antibodies
This SOX10 antibody is un-conjugated
Application
All applications for SOX10 antibodies
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Purpose
Anti - Human SOX10
Specificity
Human SOX10
Immunogen
Peptide derived from C-terminal sequence of human SOX-10. Antibody recognizes the epitope between Ser440-Leu463.
Clone
I25-T
Isotype
IgG
Top Product
Discover our top product SOX10 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
Ready to use antibody dilution. Directly use for application
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
+4˚C, Do not freeze!
Target Details for SOX10
(hide)
Target
SOX10
(SRY (Sex Determining Region Y)-Box 10 (SOX10))
Alternative Name
SOX10 (SOX10 Products )
Background
SOX-10 (SRY-Box Transcription Factor-10), SOX10 belong to the family of transcription factors, involved in the regulation of embryonic development. In cancer diagnostics, SOX10 identifies melanomas and tumors of neural crest origin. SOX10 is also highly expressed in astrocytomas, poorly differentiated glioblastomas, and in a majority of oligodendrogliomas.
UniProt
P56693
Pathways
Chromatin Binding
Recently viewed
(hide)
Chat with us , powered by LiveChat